Selenium has been the focus of considerable recent attention for its potential in reducing prostate cancer incidence. For over 25 years, selenium has been shown to be effective in preventing cancer in animal models, and human epidemiological and supplementation studies have suggested this essential trace element is effective in human as well. The mechanism of action, however, remains unknown. Selenium is a component of several dozen proteins in mammals, and recent genetic data has indicated that allelic variants of at least two selenoproteins are associated with cancer risk and/or etiology. This application is designed to study the role of selenium and selenoproteins in prostate cancer by developing a unique mouse model in which two transgenic animals are crossed: one develops prostate cancer as a result of the targeted expression of the early region of SV40 to the prostate, and the other has reduced selenoprotein levels as a result of the dominant action of a tRNA required for the synthesis of all selenium-containing proteins. These animals will be crossed to test the hypothesis that reduced selenoprotein levels will increase the incidence of pre-neoplastic lesions and tumors to the prostate, and accelerate their appearance. Animal studies will be conducted to determine whether selenium provided in the diet of these animals can influence prostate cancer development in each of the above described genetic backgrounds, as to provide mechanistic data to whether the protection provided by selenium is mediated through selenoproteins or non-selenoprotein compounds. Human prostate cells will also be used in cell culture to address the hypothesis that selenoproteins are protective by stimulating cell signaling molecules that ultimately influence DNA damage repair, and the effects of altered selenoprotein levels on these pathways in mouse prostates will be determined. Establishing a link between prostate cancer prevention, selenium and selenoprotein levels could lead to additional studies to maximize the protective effects of selenium and reduce prostate cancer incidence.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA101053-01A1
Application #
6783049
Study Section
Special Emphasis Panel (ZCA1-SRRB-D (J2))
Program Officer
Kim, Young Shin
Project Start
2004-06-23
Project End
2008-05-31
Budget Start
2004-06-23
Budget End
2005-05-31
Support Year
1
Fiscal Year
2004
Total Cost
$287,580
Indirect Cost
Name
University of Illinois at Chicago
Department
Nutrition
Type
Schools of Allied Health Profes
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Aashique, Md; Roy, Amrita; Diamond, Alan et al. (2018) Subcellular compartmentalization of glutathione peroxidase 1 allelic isoforms differentially impact parameters of energy metabolism. J Cell Biochem :
Ekoue, Dede N; He, Chenxia; Diamond, Alan M et al. (2017) Manganese superoxide dismutase and glutathione peroxidase-1 contribute to the rise and fall of mitochondrial reactive oxygen species which drive oncogenesis. Biochim Biophys Acta Bioenerg 1858:628-632
Hart, Peter C; Mao, Mao; de Abreu, Andre Luelsdorf P et al. (2015) MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer. Nat Commun 6:6053
Zhuo, Pin; Diamond, Alan M (2009) Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta 1790:1546-54
Esser, Karyn A; Harpole, Clifford E; Prins, Gail S et al. (2009) Physical activity reduces prostate carcinogenesis in a transgenic model. Prostate 69:1372-7
Baliga, Manjeshwar S; Diwadkar-Navsariwala, Veda; Koh, Timothy et al. (2008) Selenoprotein deficiency enhances radiation-induced micronuclei formation. Mol Nutr Food Res 52:1300-4
Hu, Ya Jun; Li, Zong Fang; Diamond, Alan M (2007) Enhanced discrimination of single nucleotide polymorphism in genotyping by phosphorothioate proofreading allele-specific amplification. Anal Biochem 369:54-9
Baliga, Manjeshwar S; Wang, Hengbing; Zhuo, Pin et al. (2007) Selenium and GPx-1 overexpression protect mammalian cells against UV-induced DNA damage. Biol Trace Elem Res 115:227-42
Diwadkar-Navsariwala, Veda; Prins, Gail S; Swanson, Steven M et al. (2006) Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc Natl Acad Sci U S A 103:8179-84